Characterization of human and mouse cartilage oligomeric matrix protein
about
Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changesCartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritisCartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrinsInteraction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecanPseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein geneA mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneityCartilage oligomeric matrix protein-deficient mice have normal skeletal development.Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrumCOL9A3: A third locus for multiple epiphyseal dysplasia.Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression dataPseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlationsMutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasiaSelection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor.A novel COMP mutation in a pseudoachondroplasia family of Chinese origin.Phylogenomic analysis of vertebrate thrombospondins reveals fish-specific paralogues, ancestral gene relationships and a tetrapod innovation.Pseudoachondroplastic dysplasia: an Iowa review from human to mouseIdentification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens.Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.Cartilage oligomeric matrix protein promotes cell attachment via two independent mechanisms involving CD47 and alphaVbeta3 integrin.The thrombospondins.Enhanced activity of transforming growth factor β1 (TGF-β1) bound to cartilage oligomeric matrix protein.Members of the thrombospondin gene family bind stromal interaction molecule 1 and regulate calcium channel activityNeutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expressionCOMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasiaPost-translational modifications in cartilage oligomeric matrix protein. Characterization of the N-linked oligosaccharides by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.Insider trading: Extracellular matrix proteins and their non-canonical intracellular roles.Osteogenic Potential of the Transcription Factor c-MYB.Modulation of the extracellular matrix patterning of thrombospondins by actin dynamics and thrombospondin oligomer state.Pseudoachondroplasia is caused through both intra- and extracellular pathogenic pathways.Painful locking of the wrist in a patient with pseudoachondroplasia confirmed by COMP mutation.Progress in human chondrodysplasias: molecular genetics.Mutations in the cartilage oligomeric matrix protein (COMP) gene in pseudoachondroplasia and multiple epiphyseal dysplasia.Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3.Metabolism of thrombospondin 2. Binding and degradation by 3t3 cells and glycosaminoglycan-variant Chinese hamster ovary cells.Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene.Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.Altered synthesis of cartilage-specific proteoglycans by mutant human cartilage oligomeric matrix protein.COMP-lex Mechanics: Matricrine Signaling.Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes.Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases.
P2860
Q22254372-E2244104-D462-4126-986A-4AC24DC7AEA3Q24307967-86246F88-0564-4D04-8D30-314350C38B7DQ24310801-E2FB8881-E4B3-446B-B66A-C336DA5E3098Q24313450-1D58322F-B097-45FA-A49F-22B635E4D423Q24337332-D1BD0595-3D24-4ABE-A956-17A1C3308968Q24536139-DE277FB3-F262-42E5-B3EE-BCD1D96773C9Q24537474-E0E631C5-B840-4688-A46B-4455E2F1F1A8Q24538707-4C9392BA-6F4F-4786-A731-0FCFE82A918FQ24540189-6A0E199D-0D12-487B-A383-184ED6B28696Q24684071-B0F64EE7-0624-4EBB-9FB4-6ABFDA2103AAQ28215523-709A899D-6B34-49BA-A7B0-B0135AA3CF28Q28297153-2CDB6B02-AB1C-4D94-8B32-AEFC1600EE7DQ30988881-C0D4929E-7DC6-4BCC-8137-58BC1064901EQ31014676-3196B841-4176-4CD7-90FA-E9561FD9A5E4Q33240160-610CEA8B-8CA9-4EA5-BE1C-3CDE9D1103A8Q33939780-9D5244C0-A031-447A-8375-F4374E59496EQ34533360-CEE9BF5F-5945-448E-B443-7256DD5D48F0Q35077927-16BCB4AD-0736-4BEE-985F-9D91A80BCBABQ35149818-DC8AFEC2-4187-4C3F-A179-D2FC6CA9D4EDQ35230013-606D451C-C839-4650-8CE4-227368333AC6Q35604546-2AF05EBA-73FF-44C6-BC3F-9BCEA8D9155FQ35853594-6154D288-CDAF-448A-9C31-28FEA9BA6119Q35928277-A4FB09E6-0AD4-4EFC-B605-0D3B5CF752E4Q36065648-B0B2E91B-4811-4514-954E-582A29A75086Q36862402-FF81B794-6EF4-4630-AE98-882B145A490FQ38688202-D7D306E3-F657-4F25-B9FD-0443AC6B8B47Q38778563-D1BF541D-22C9-4016-B5B8-F68925F7CBB2Q38852212-4CC60489-DC8D-47AB-9B2D-02A9952342D5Q39735942-A465276B-B8BC-4625-A231-073C6778DD26Q40460068-C4E996C8-F608-4FF8-ADAF-65735E5E830DQ41029788-32B86848-F81F-457F-9379-E7B55EF23D14Q41029816-307384E4-72D6-41B0-8CFF-39A05A3E944EQ41197594-2E95F217-11BF-4BDC-B9A5-D8D6BCE6BAE6Q41930413-A961D518-18AB-4400-8BD7-3F5A3A63F3E0Q41942487-38D22605-D986-4424-8C7F-5FADE5A448F7Q41984401-EAF35EA7-32CE-4016-BB65-4482D27CAA1DQ42271243-4FA3E981-1E71-44DD-801F-995D4E418796Q42426286-D6F763ED-56FB-4660-9EC8-55B63959ABD8Q42456658-32FD9417-5ABD-44C8-B2C1-20C6C53B5A51Q43141526-6484B513-0168-48A6-AD3F-8482AA0FCA46
P2860
Characterization of human and mouse cartilage oligomeric matrix protein
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Characterization of human and mouse cartilage oligomeric matrix protein
@ast
Characterization of human and mouse cartilage oligomeric matrix protein
@en
Characterization of human and mouse cartilage oligomeric matrix protein
@en-gb
Characterization of human and mouse cartilage oligomeric matrix protein
@nl
type
label
Characterization of human and mouse cartilage oligomeric matrix protein
@ast
Characterization of human and mouse cartilage oligomeric matrix protein
@en
Characterization of human and mouse cartilage oligomeric matrix protein
@en-gb
Characterization of human and mouse cartilage oligomeric matrix protein
@nl
prefLabel
Characterization of human and mouse cartilage oligomeric matrix protein
@ast
Characterization of human and mouse cartilage oligomeric matrix protein
@en
Characterization of human and mouse cartilage oligomeric matrix protein
@en-gb
Characterization of human and mouse cartilage oligomeric matrix protein
@nl
P2093
P356
P1433
P1476
Characterization of human and mouse cartilage oligomeric matrix protein
@en
P2093
C C Morton
D J Gilbert
N A Jenkins
N G Copeland
S Weremowicz
P356
10.1006/GENO.1994.1649
P407
P577
1994-12-01T00:00:00Z